APPLICATION
ANDA077005
TYPE
ANDA
ORIGINAL APPROVAL
2005-07-13
LATEST ACTION
2015-03-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 12.5MG · CAPSULE · ORAL
Approval history
2015-03-18Manufacturing (CMC) · Supplement 8AP
2006-06-21Labeling · Supplement 2AP
2005-07-13OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.